Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Explainable AI framework for psilocybin depression treatment optimizationFrontiers in Computer Science · 2026-03-16Behavioral and neuronal effects of psilocybin in miceNeuroscience Applied · 2026-01-01The entropic brain todayPsyArXiv · 2025-12-12Blunted psychedelic drug effects in older adultsPsyArXiv · 2025-09-04Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-07-15An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depressionPsyArXiv · 2025-07-06Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use DisorderPsyArXiv · 2025-06-10Meditation and psychedelics facilitate similar types of mystical, psychological, and philosophical-existential insights predictive of wellbeing: A qualitative-quantitative approachPsyArXiv · 2025-06-06Age and cannabis co-use moderate experience and perceived benefits of psilocybinPsyArXiv · 2025-05-22Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatmentsPsyArXiv · 2025-05-16Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-03-29Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious communityPsyArXiv · 2025-03-27Psychedelics and autobiographical memory - Six open questionsPsyArXiv · 2025-03-11Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing StudyPsyArXiv · 2025-03-07Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online samplePsyArXiv · 2025-02-28Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing MushroomsPsyArXiv · 2025-02-28Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing MushroomsPsyArXiv · 2025-02-28The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.PsyArXiv · 2025-02-25The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.PsyArXiv · 2025-02-24Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-02-13Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing MushroomsPsyArXiv · 2024-11-07Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing MushroomsPsyArXiv · 2024-11-07Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trialPsyArXiv · 2024-11-04Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin ExpertsPsyArXiv · 2024-10-31The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsPsyArXiv · 2024-10-22Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.PsyArXiv · 2024-10-18Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.PsyArXiv · 2024-10-18Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review ProtocolPsyArXiv · 2024-10-07From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.PsyArXiv · 2024-10-01From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.PsyArXiv · 2024-10-01Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-usersPsyArXiv · 2024-07-28Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectanciesPsyArXiv · 2024-06-105-MeO-DMT in the complete resolution of the consequences of chronic, severe sexual abuse in early childhood-a retrospective case studyPsyArXiv · 2024-06-07Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMAPsyArXiv · 2024-06-07Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related PsychopathologyPsyArXiv · 2024-05-26Methodological issues undermine evidence about adverse effects of psilocybin-assisted psychotherapyPsyArXiv · 2024-05-17Do undergraduates’ views of psychedelics relate to the context for psychedelic use?PsyArXiv · 2024-04-24Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical studyPsyArXiv · 2024-01-11Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and OverviewPsyArXiv · 2023-12-26Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. PsilocybinPsyArXiv · 2023-12-26Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approachPsyArXiv · 2023-11-22A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issuesPsyArXiv · 2023-10-27Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin usePsyArXiv · 2023-10-14Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin usePsyArXiv · 2023-10-14Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomised semi-naturalistic-lab feasibility studyPsyArXiv · 2023-10-11“Diversity makes the richness of humanity”: the emergence of mental imagery after self-reported psilocybin mushrooms intake in an autistic woman with “blind imagination” (aphantasia): a 1-year retrospective case reportPsyArXiv · 2023-08-16A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial InterventionsPsyArXiv · 2023-07-18Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on PsilocybinPsyArXiv · 2023-07-06Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative studyPsyArXiv · 2023-06-30The treatment of abandonment anxiety with MDMA and LSDPsyArXiv · 2023-06-09Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal StudyPsyArXiv · 2023-06-09Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case studyPsyArXiv · 2023-06-09Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal StudyPsyArXiv · 2023-06-09The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of ConsciousnessPsyArXiv · 2023-06-04Is Microdosing a Placebo?PsyArXiv · 2023-06-04Is Microdosing a Placebo?PsyArXiv · 2023-06-04Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’PsyArXiv · 2023-04-28Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCDPsyArXiv · 2023-03-17Understanding psychedelic 'mystical experience'-A case examplePsyArXiv · 2023-03-10Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case studyPsyArXiv · 2023-03-10Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case studyPsyArXiv · 2023-03-10Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekstPsyArXiv · 2023-01-04Manuel de Yale pour la Thérapie de la Dépression Assistée par la PsilocybinePsyArXiv · 2022-11-15Serotonergic antidepressant use is associated with weaker psilocybin effectsPsyArXiv · 2022-10-28Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355PsyArXiv · 2022-10-05Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language ProcessingPsyArXiv · 2022-09-30From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)PsyArXiv · 2022-07-07A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionPsyArXiv · 2022-07-01Neuroimaging in psychedelic drug development: Past, present, and futurePsyArXiv · 2022-06-30A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed MindsPsyArXiv · 2022-05-10Skepticism About Recent Evidence that Psilocybin Opens Depressed MindsPsyArXiv · 2022-04-28Predictors of Psychedelic Experience: A Thematic AnalysisPsyArXiv · 2021-12-21A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive EffectsPsyArXiv · 2021-12-14Examining attitudes to psilocybin: Should candidates for medical psilocybin be required to pass a contextual suitability testPsyArXiv · 2021-11-23Psychedelics and Mindfulness: A Systematic Review and Meta-AnalysisPsyArXiv · 2021-10-11Naturalistic Entheogenics: Précis of Philosophy of PsychedelicsPsyArXiv · 2021-07-08Psilocybin for Depression: The ACE Model ManualPsyArXiv · 2021-07-05Psychedelic Assisted Therapy for Major Depressive Disorder: A ReviewPsyArXiv · 2021-06-27Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trialsPsyArXiv · 2021-06-14Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analysesPsyArXiv · 2021-06-10Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and WellbeingPsyArXiv · 2021-05-31Future Directions for Clinical Psilocybin Research: The Relaxed Symptom NetworkPsyArXiv · 2021-05-19New insights into the clinical and nonclinical effects of psychedelic substances: an integrative reviewPsyArXiv · 2021-05-05Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)PsyArXiv · 2021-04-02Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)PsyArXiv · 2021-03-24Blinding and Expectancy Confounds in Psychedelic Randomised Controlled TrialsPsyArXiv · 2021-03-08Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reportsPsyArXiv · 2021-02-24Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.Psychopharmacology · 2021-02-01Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic TherapyPsyArXiv · 2020-12-29A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted TherapyPsyArXiv · 2020-10-28The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)PsyArXiv · 2020-08-13Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money makingPsyArXiv · 2020-08-07A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted TherapyPsyArXiv · 2020-06-12Global Drug SurveyPsyArXiv · 2020-04-12Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosersPsyArXiv · 2018-11-02